BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12951095)

  • 1. A convenient method for the computer-aided molecular design of carborane containing compounds.
    Johnsamuel J; Byun Y; Jones TP; Endo Y; Tjarks W
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3213-6. PubMed ID: 12951095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico carborane docking to proteins and potential drug targets.
    Calvaresi M; Zerbetto F
    J Chem Inf Model; 2011 Aug; 51(8):1882-96. PubMed ID: 21774557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liposome formulations of o-carborane for the boron neutron capture therapy of cancer.
    Olusanya TOB; Calabrese G; Fatouros DG; Tsibouklis J; Smith JR
    Biophys Chem; 2019 Apr; 247():25-33. PubMed ID: 30797076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carborane clusters in computational drug design: a comparative docking evaluation using AutoDock, FlexX, Glide, and Surflex.
    Tiwari R; Mahasenan K; Pavlovicz R; Li C; Tjarks W
    J Chem Inf Model; 2009 Jun; 49(6):1581-9. PubMed ID: 19449853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of stable platinum complexes containing carborane in a carrier group for potential BNCT agents.
    Yoo J; Do Y
    Dalton Trans; 2009 Jul; (25):4978-86. PubMed ID: 19662290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
    Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
    Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrochemical Cage Activation of Carboranes.
    Yang L; Zhang ZJ; Bongsuiru Jei B; Ackermann L
    Angew Chem Int Ed Engl; 2022 May; 61(20):e202200323. PubMed ID: 35148009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational design of gold nanoparticles functionalized with carboranes for application in Boron Neutron Capture Therapy.
    Ciani L; Bortolussi S; Postuma I; Cansolino L; Ferrari C; Panza L; Altieri S; Ristori S
    Int J Pharm; 2013 Dec; 458(2):340-6. PubMed ID: 24140178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Phthalocyanine-ortho-Carborane Conjugate for Boron Neutron Capture Therapy: Synthesis, Physicochemical Properties, and in vitro Tests.
    Nar I; Bortolussi S; Postuma I; Atsay A; Berksun E; Viola E; Ferrari C; Cansolino L; Ricciardi G; Donzello MP; Hamuryudan E
    Chempluschem; 2019 Apr; 84(4):345-351. PubMed ID: 31939222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of multivalent galactosyl carborane as a targeting specific agent for potential application to boron neutron capture therapy.
    Lai CH; Lin YC; Chou FI; Liang CF; Lin EW; Chuang YJ; Lin CC
    Chem Commun (Camb); 2012 Jan; 48(4):612-4. PubMed ID: 22114760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of monosubstituted functional derivatives of carboranes from 1-mercapto-ortho-carborane: 1-HOOC(CH(2))(n)S-1,2-C(2)B(10)H(11) and [7-HOOC(CH(2))(n)S-7,8-C(2)B(9)H(11)](-) (n = 1-4).
    Stogniy MY; Sivaev IB; Petrovskii PV; Bregadze VI
    Dalton Trans; 2010 Feb; 39(7):1817-22. PubMed ID: 20449427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting Blood Transport Proteins as Carborane Supramolecular Vehicles for Boron Neutron Capture Therapy.
    Marforio TD; Mattioli EJ; Zerbetto F; Calvaresi M
    Nanomaterials (Basel); 2023 May; 13(11):. PubMed ID: 37299673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,2-Diphenyl-
    Ha TJ; Im DK; Kim SM; Lee JD
    Molecules; 2023 Jun; 28(13):. PubMed ID: 37446604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards carborane-functionalised structures for the treatment of brain cancer.
    Calabrese G; Daou A; Barbu E; Tsibouklis J
    Drug Discov Today; 2018 Jan; 23(1):63-75. PubMed ID: 28886331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carborane derivatives loaded into liposomes as efficient delivery systems for boron neutron capture therapy.
    Altieri S; Balzi M; Bortolussi S; Bruschi P; Ciani L; Clerici AM; Faraoni P; Ferrari C; Gadan MA; Panza L; Pietrangeli D; Ricciardi G; Ristori S
    J Med Chem; 2009 Dec; 52(23):7829-35. PubMed ID: 19954249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboranes as unique pharmacophores in antitumor medicinal chemistry.
    Chen Y; Du F; Tang L; Xu J; Zhao Y; Wu X; Li M; Shen J; Wen Q; Cho CH; Xiao Z
    Mol Ther Oncolytics; 2022 Mar; 24():400-416. PubMed ID: 35141397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Site-Selective Functionalization of Carboranes at the Electron-Rich Boron Vertex: Photocatalytic B-C Coupling via a Carboranyl Cage Radical.
    Chen M; Xu J; Zhao D; Sun F; Tian S; Tu D; Lu C; Yan H
    Angew Chem Int Ed Engl; 2022 Sep; 61(37):e202205672. PubMed ID: 35670361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Modeling of the Interactions between Carborane-Containing Analogs of Indomethacin and Cyclooxygenase-2.
    Sárosi MB; Neumann W; Lybrand TP; Hey-Hawkins E
    J Chem Inf Model; 2017 Aug; 57(8):2056-2067. PubMed ID: 28632381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In Vivo Application of Carboranes for Boron Neutron Capture Therapy (BNCT): Structure, Formulation and Analytical Methods for Detection.
    Marforio TD; Carboni A; Calvaresi M
    Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a carborane-containing cholesterol derivative and evaluation as a potential dual agent for MRI/BNCT applications.
    Alberti D; Toppino A; Geninatti Crich S; Meraldi C; Prandi C; Protti N; Bortolussi S; Altieri S; Aime S; Deagostino A
    Org Biomol Chem; 2014 Apr; 12(15):2457-67. PubMed ID: 24604345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.